{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:25:59Z","timestamp":1707524759280},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,24]]},"DOI":"10.7759\/cureus.29521","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T09:34:13Z","timestamp":1664012053000},"source":"Crossref","is-referenced-by-count":0,"title":["Atypical Guillain-Barr\u00e9 Syndrome Presenting After COVID-19 Infection"],"prefix":"10.7759","author":[{"given":"Aleeha","family":"Noon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasminder K","family":"Malhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung Ki","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria","volume":"137","author":"Fokke C","year":"2014","unstructured":"Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria. Brain. 2014, 137:33-43. 10.1093\/brain\/awt285","journal-title":"Brain"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard SE","year":"2019","unstructured":"Leonhard SE, Mandarakas MR, Gondim FA, et al.. Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps. Nat Rev Neurol. 2019, 15:671-83. 10.1038\/s41582-019-0250-9","journal-title":"Nat Rev Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb09683.x","article-title":"Molecular mimicry in Guillain-Barr\u00e9 syndrome","volume":"845","author":"Sheikh KA","year":"1998","unstructured":"Sheikh KA, Ho TW, Nachamkin I, et al.. Molecular mimicry in Guillain-Barr\u00e9 syndrome. Ann N Y Acad Sci. 1998, 845:307-21. 10.1111\/j.1749-6632.1998.tb09683.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-200110000-00009","article-title":"Epidemiology of the Guillain-Barr\u00e9 syndrome","volume":"14","author":"Govoni V","year":"2001","unstructured":"Govoni V, Granieri E. Epidemiology of the Guillain-Barr\u00e9 syndrome. Curr Opin Neurol. 2001, 14:605-13. 10.1097\/00019052-200110000-00009","journal-title":"Curr Opin Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-019-2157-x","article-title":"Guillain-Barr\u00e9 syndrome with associated unilateral ptosis without ophthalmoplegia - a rare presentation: a case report and review of the literature","volume":"13","author":"Ralapanawa U","year":"2019","unstructured":"Ralapanawa U, Kumarihamy P, Jayalath T, Udupihille J. Guillain-Barr\u00e9 syndrome with associated unilateral ptosis without ophthalmoplegia - a rare presentation: a case report and review of the literature. J Med Case Rep. 2019, 13:221. 10.1186\/s13256-019-2157-x","journal-title":"J Med Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27 Suppl","author":"Asbury AK","year":"1990","unstructured":"Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome. Ann Neurol. 1990, 27 Suppl:S21-4. 10.1002\/ana.410270707","journal-title":"Ann Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.19809","article-title":"COVID-19-induced Guillain-Barr\u00e9 syndrome","volume":"13","author":"Brooks JE","year":"2021","unstructured":"Brooks JE, Mix FM, Buck JC, Walters RA. COVID-19-induced Guillain-Barr\u00e9 syndrome. Cureus. 2021, 13:e19809. 10.7759\/cureus.19809","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0687-z","article-title":"An unusual case of recurrent Guillain-Barr\u00e9 syndrome with normal cerebrospinal fluid protein levels: a case report","volume":"16","author":"Gunatilake SS","year":"2016","unstructured":"Gunatilake SS, Gamlath R, Wimalaratna H. An unusual case of recurrent Guillain-Barr\u00e9 syndrome with normal cerebrospinal fluid protein levels: a case report. BMC Neurol. 2016, 16:161. 10.1186\/s12883-016-0687-z","journal-title":"BMC Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0000000000000119","article-title":"Human immunoglobulin versus plasmapheresis in Guillain-Barre Syndrome and myasthenia gravis: a meta-analysis","volume":"18","author":"Ortiz-Salas P","year":"2016","unstructured":"Ortiz-Salas P, Velez-Van-Meerbeke A, Galvis-Gomez CA, Rodriguez Q JH. Human immunoglobulin versus plasmapheresis in Guillain-Barre Syndrome and myasthenia gravis: a meta-analysis. J Clin Neuromuscul Dis. 2016, 18:1-11. 10.1097\/CND.0000000000000119","journal-title":"J Clin Neuromuscul Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome. Dutch Guillain-Barr\u00e9 Study Group","volume":"326","author":"van der Mech\u00e9 FG","year":"1992","unstructured":"van der Mech\u00e9 FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome. Dutch Guillain-Barr\u00e9 Study Group. N Engl J Med. 1992, 326:1123-9. 10.1056\/NEJM199204233261705","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/aian.AIAN_345_17","article-title":"Phrenic nerve conduction study in the early stage of Guillain-Barre syndrome as a predictor of respiratory failure","volume":"21","author":"Sen BK","year":"2018","unstructured":"Sen BK, Pandit A. Phrenic nerve conduction study in the early stage of Guillain-Barre syndrome as a predictor of respiratory failure. Ann Indian Acad Neurol. 2018, 21:57-61. 10.4103\/aian.AIAN_345_17","journal-title":"Ann Indian Acad Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27506","article-title":"Causes and consequences of diagnostic delay in Guillain-Barr\u00e9 syndrome in a UK tertiary center","volume":"65","author":"Bose S","year":"2022","unstructured":"Bose S, Loo LK, Rajabally YA. Causes and consequences of diagnostic delay in Guillain-Barr\u00e9 syndrome in a UK tertiary center. Muscle Nerve. 2022, 65:547-52. 10.1002\/mus.27506","journal-title":"Muscle Nerve"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/114505-atypical-guillain-barr-syndrome-presenting-after-covid-19-infection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:37Z","timestamp":1707508117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/114505-atypical-guillain-barr-syndrome-presenting-after-covid-19-infection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,24]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.29521","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,24]]}}}